Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
ALL-82 protocol
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
ALL-82 protocol
Unique ID
C471581
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C471581
Registry Numbers
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Doxorubicin
Methotrexate
Teniposide
Mercaptopurine
/
analogs & derivatives
Frequency
1
Note
chemotherapy protocol consisting of methotrexate,
VM-26
, doxorubicin, cytarabine, 6-methylmercaptopurine, and CTX for the treatment of acute lymphoid leukemia
Source
Leuk Res 2003 Jan;27(1):45-50
Date of Entry
2003/03/01
Revision Date
2013/11/06
Expand All
Collapse All
ALL-82 protocol
Preferred
Concept UI
M0446286
Registry Numbers
0
Terms
ALL-82 protocol
Preferred Term
Term UI
T534197
Date
03/01/2003
LexicalTag
NON
ThesaurusID
NLM (2003)
page delivered in 0.002s